Skip to Content
Merck
All Photos(1)

Documents

MAB8150

Sigma-Aldrich

Anti-West Nile Virus/Kunjin Antibody, Envelope, clone 3.67G

clone 3.67G, Chemicon®, from mouse

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

3.67G, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

isotype

IgG1

shipped in

wet ice

Specificity

Specific for the major envelope protein E of West Nile/Kunjin virus. Kunjin (KUN) is very closely related to some strains of West Nile virus, and has been classified as a subtype of West Nile.

Immunogen

Epitope: Envelope

Application

Anti-West Nile Virus/Kunjin Antibody, Envelope, clone 3.67G detects level of West Nile Virus/Kunjin & has been published & validated for use in ELISA, IF, WB, IH.

Physical form

Format: Purified
Purified immunoglobulin in 0.02 M phosphate buffer, 0.25M NaCl, pH 7.6 with 0.1% Sodium Azide.

Storage and Stability

Maintain at 2-8°C in undiluted aliquots.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ana B Blázquez et al.
Frontiers in microbiology, 7, 296-296 (2016-03-26)
West Nile virus (WNV) is a mosquito-borne flavivirus maintained in a transmission cycle between mosquitoes and birds, but it can also infect other vertebrates, including humans, in which it can cause neuroinvasive diseases. To date, no licensed vaccine or therapy
A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice.
Nzonza, A; Lecollinet, S; Chat, S; Lowenski, S; Merour, E; Biacchesi, S; Bremont, M
Testing null
Miguel A Martín-Acebes et al.
Journal of lipid research, 57(3), 422-432 (2016-01-15)
Flaviviruses, such as the dengue virus and the West Nile virus (WNV), are arthropod-borne viruses that represent a global health problem. The flavivirus lifecycle is intimately connected to cellular lipids. Among the lipids co-opted by flaviviruses, we have focused on
Himanshu Garg et al.
Journal of virology, 91(20) (2017-08-11)
Recent worldwide outbreaks of Zika virus (ZIKV) infection and the lack of an approved vaccine raise serious concerns regarding preparedness to combat this emerging virus. We used a virus-like particle (VLP)-based approach to develop a vaccine and a microneutralization assay
Nereida Jiménez de Oya et al.
Emerging microbes & infections, 8(1), 624-636 (2019-04-20)
Flaviviruses are (re)-emerging RNA viruses strictly dependent on lipid metabolism for infection. In the search for host targeting antivirals, we explored the effect of pharmacological modulation of fatty acid metabolism during flavivirus infection. Considering the central role of acetyl-Coenzyme A

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service